Literature DB >> 22950421

Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease.

Rosanna Squitti1, Renato Polimanti, Serena Bucossi, Mariacarla Ventriglia, Stefania Mariani, Dario Manfellotto, Fabrizio Vernieri, Emanuele Cassetta, Francesca Ursini, Paolo Maria Rossini.   

Abstract

Copper dyshomeostasis leading to a labile Cu(2+) not bound to ceruloplasmin ("free" copper) may influence Alzheimer's disease (AD) onset or progression. To investigate this hypothesis, we investigated ATP7B, the gene that controls copper excretion through the bile and concentrations of free copper in systemic circulation. Our study analyzed informative ATP7B single-nucleotide polymorphisms (SNPs) in a case-control population (n=515). In particular, we evaluated the genetic structure of the ATP7B gene using the HapMap database and carried out a genetic association investigation. Linkage disequilibrium (LD) analysis highlighted that our informative SNPs and their LD SNPs covered 96% of the ATP7B gene sequence, distinguishing two "strong LD" blocks. The first LD block contains the gene region encoding for transmembrane and copper-binding, whereas the second LD block encodes for copper-binding domains. The genetic association analysis showed significant results after multiple testing correction for all investigated variants (rs1801243, odds ratio [OR]=1.52, 95% confidence interval [CI]=1.10-2.09, p=0.010; rs2147363, OR=1.58, 95% CI=1.11-2.25, p=0.010; rs1061472, OR=1.73, 95% CI=1.23-2.43, p=0.002; rs732774, OR=2.31, 95% CI=1.41-3.77, p<0.001), indicating that SNPs in transmembrane domains may have a stronger association with AD risk than variants in copper-binding domains. Our study provides novel insights that confirm the role of ATP7B as a potential genetic risk factor for AD. The analysis of ATP7B informative SNPs confirms our previous hypothesis about the absence of ATP7B in the significant loci of genome-wide association studies of AD and the genetic association study suggests that transmembrane and adenosine triphosphate (ATP) domains in the ATP7B gene may harbor variants/haplotypes associated with AD risk.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22950421      PMCID: PMC3582274          DOI: 10.1089/rej.2012.1357

Source DB:  PubMed          Journal:  Rejuvenation Res        ISSN: 1549-1684            Impact factor:   4.663


  34 in total

1.  The structure of haplotype blocks in the human genome.

Authors:  Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler
Journal:  Science       Date:  2002-05-23       Impact factor: 47.728

2.  Copper in Alzheimer disease: too much, too little, or misplaced?

Authors:  Peter Faller
Journal:  Free Radic Biol Med       Date:  2011-11-11       Impact factor: 7.376

3.  Functional analysis of mutations in the ATP loop of the Wilson disease copper transporter, ATP7B.

Authors:  Leiah M Luoma; Taha M M Deeb; Georgina Macintyre; Diane W Cox
Journal:  Hum Mutat       Date:  2010-05       Impact factor: 4.878

4.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

5.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

6.  Diverse functional properties of Wilson disease ATP7B variants.

Authors:  Dominik Huster; Angelika Kühne; Ashima Bhattacharjee; Lily Raines; Vanessa Jantsch; Johannes Noe; Wiebke Schirrmeister; Ines Sommerer; Osama Sabri; Frieder Berr; Joachim Mössner; Bruno Stieger; Karel Caca; Svetlana Lutsenko
Journal:  Gastroenterology       Date:  2012-01-10       Impact factor: 22.682

7.  Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

Authors:  R Squitti; G Barbati; L Rossi; M Ventriglia; G Dal Forno; S Cesaretti; F Moffa; I Caridi; E Cassetta; P Pasqualetti; L Calabrese; D Lupoi; P M Rossini
Journal:  Neurology       Date:  2006-07-11       Impact factor: 9.910

8.  Elevated labile Cu is associated with oxidative pathology in Alzheimer disease.

Authors:  Simon A James; Irene Volitakis; Paul A Adlard; James A Duce; Colin L Masters; Robert A Cherny; Ashley I Bush
Journal:  Free Radic Biol Med       Date:  2011-10-24       Impact factor: 7.376

9.  Molecular diagnosis of Wilson disease using prevalent mutations and informative single-nucleotide polymorphism markers.

Authors:  Arnab Gupta; Mahua Maulik; Poonam Nasipuri; Ishita Chattopadhyay; Shyamal K Das; Prasanta K Gangopadhyay; Kunal Ray
Journal:  Clin Chem       Date:  2007-07-18       Impact factor: 8.327

Review 10.  Agents complexing copper as a therapeutic strategy for the treatment of Alzheimer's disease.

Authors:  Rosanna Squitti; Carlo Salustri
Journal:  Curr Alzheimer Res       Date:  2009-12       Impact factor: 3.498

View more
  18 in total

1.  Non-Ceruloplasmin Copper Distincts Subtypes in Alzheimer's Disease: a Genetic Study of ATP7B Frequency.

Authors:  Rosanna Squitti; Mariacarla Ventriglia; Massimo Gennarelli; Nicola A Colabufo; Imane Ghafir El Idrissi; Serena Bucossi; Stefania Mariani; Mauro Rongioletti; Orazio Zanetti; Chiara Congiu; Paolo M Rossini; Cristian Bonvicini
Journal:  Mol Neurobiol       Date:  2016-01-12       Impact factor: 5.590

2.  Single nucleotide polymorphisms in the human ATP7B gene modify the properties of the ATP7B protein.

Authors:  Courtney J McCann; Samuel Jayakanthan; Mariacristina Siotto; Nan Yang; Maria Osipova; Rosanna Squitti; Svetlana Lutsenko
Journal:  Metallomics       Date:  2019-06-19       Impact factor: 4.526

3.  In Vivo Modeling of the Pathogenic Effect of Copper Transporter Mutations That Cause Menkes and Wilson Diseases, Motor Neuropathy, and Susceptibility to Alzheimer's Disease.

Authors:  Stephen W Mercer; Jianbin Wang; Richard Burke
Journal:  J Biol Chem       Date:  2017-01-24       Impact factor: 5.157

Review 4.  Avoiding Alzheimer's disease: The important causative role of divalent copper ingestion.

Authors:  George J Brewer
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-06

Review 5.  Exploring the Role of CLU in the Pathogenesis of Alzheimer's Disease.

Authors:  Md Sahab Uddin; Md Tanvir Kabir; Mst Marium Begum; Md Siddiqul Islam; Tapan Behl; Ghulam Md Ashraf
Journal:  Neurotox Res       Date:  2020-08-21       Impact factor: 3.911

6.  ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease.

Authors:  Rosanna Squitti; Renato Polimanti; Mariacristina Siotto; Serena Bucossi; Mariacarla Ventriglia; Stefania Mariani; Fabrizio Vernieri; Federica Scrascia; Laura Trotta; Paolo Maria Rossini
Journal:  Neuromolecular Med       Date:  2013-06-13       Impact factor: 3.843

7.  Copper phenotype in Alzheimer's disease: dissecting the pathway.

Authors:  Rosanna Squitti; Renato Polimanti
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

Review 8.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

Review 9.  Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders.

Authors:  Sarah van Veen; Danny M Sørensen; Tine Holemans; Henrik W Holen; Michael G Palmgren; Peter Vangheluwe
Journal:  Front Mol Neurosci       Date:  2014-05-27       Impact factor: 5.639

10.  Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis.

Authors:  Jonathon Telianidis; Ya Hui Hung; Stephanie Materia; Sharon La Fontaine
Journal:  Front Aging Neurosci       Date:  2013-08-23       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.